Loading...
Addition of docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): modelling to estimate long-term survival, quality-adjusted survival, and cost-effectiveness
Woods, BS Sideris, E Sydes, MR Gannon, MR Parmar, MKB Alzouebi, M Attard, G Birtle, AJ Brock, S Cathomas, R
Woods, BS
Sideris, E
Sydes, MR
Gannon, MR
Parmar, MKB
Alzouebi, M
Attard, G
Birtle, AJ
Brock, S
Cathomas, R
Citations
Altmetric:
Abstract
Authors
Woods, BS
Sideris, E
Sydes, MR
Gannon, MR
Parmar, MKB
Alzouebi, M
Attard, G
Birtle, AJ
Brock, S
Cathomas, R
Chakraborti, PR
Cook, A
Cross, WR
Dearnaley, D
Gale, J
Gibbs, S
Graham, JD
Hughes, R
Jones, RJ
Laing, R
Mason, MD
Matheson, D
McLaren, DB
Millman, R
O'Sullivan, JM
Parikh, O
Parker, CC
Peedell, C
Protheroe, A
Ritchie, AWS
Robinson, A
Russell, JM
Simms, MS
Srihari, NN
Srinivasan, R
Staffurth, JN
Sundar, S
Thalmann, GN
Tolan, S
Tran, Anna T
Tsang, D
Wagstaff, J
James, ND
Sculpher, MJ
Sideris, E
Sydes, MR
Gannon, MR
Parmar, MKB
Alzouebi, M
Attard, G
Birtle, AJ
Brock, S
Cathomas, R
Chakraborti, PR
Cook, A
Cross, WR
Dearnaley, D
Gale, J
Gibbs, S
Graham, JD
Hughes, R
Jones, RJ
Laing, R
Mason, MD
Matheson, D
McLaren, DB
Millman, R
O'Sullivan, JM
Parikh, O
Parker, CC
Peedell, C
Protheroe, A
Ritchie, AWS
Robinson, A
Russell, JM
Simms, MS
Srihari, NN
Srinivasan, R
Staffurth, JN
Sundar, S
Thalmann, GN
Tolan, S
Tran, Anna T
Tsang, D
Wagstaff, J
James, ND
Sculpher, MJ
Description
Date
2019
Publisher
Collections
Files
Keywords
Type
Article
Citation
Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, et al. Addition of docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): modelling to estimate long-term survival, quality-adjusted survival, and cost-effectiveness. Eur Urol Oncol. 2018 Dec;1(6):449-58.